Covid-19 vaccine

Article

October 18, 2021

The 2019 coronavirus vaccine is a vaccine that aims to build immunity against the coronavirus that causes COVID-19. Before the outbreak of COVID-19 Efforts have been ongoing to develop vaccines for coronaviruses that cause other diseases, such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). continually These efforts have accumulated considerable knowledge about the structure and function of the coronavirus. This has helped the development of various coronavirus vaccine technologies from the beginning of 2020 to proceed quickly. Starting on January 10, 2020, when gene sequencing was published through GISAID (GISAID), and as of March 19, the global pharmaceutical industry announced a commitment to manage the disease. Covid-19 vaccine It is generally credited for reducing infection, severity and disease-related mortality in phase 3 clinical trials. Several vaccines protect against symptomatic infection with up to 95 percent efficacy. As of July 2021, there are 20 vaccines registered for use in at least one country, including two RNA vaccines (Pfizer and Moderna), 9 deadly COVID-19 vaccines (Sino Farm's BBIBP-CorV, Chinese Academy of Medical Sciences vaccine, Sinovac, Parat Biotech's Covaxin, Chumakov Centre's CoviVac, Shifa Pharmed Industrial Group's COVIran Barakat, Minhai- Kangtai (KCONVAC), Research Institute for Biological Safety Problems QazVac and Sino Farm's WIBP-CorV) Five vector virus-based vaccines (Gamalia Research Institute's Sputnik Light and Sputnik V, AstraZeneca, Canon Biologics Ad5-nCoV, and Johnson & Johnson) and the viral subunit vaccine

INSERT INTO `wiki_article`(`id`, `article_id`, `title`, `article`, `img_url`) VALUES ('NULL()','วัคซีนโรคติดเชื้อไวรัสโคโรนา_2019','Covid-19 vaccine','','')